Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
AssigneeSugen, Inc.
InventorsGregory Plowman, Kevin Mossie
Life of this patent
Estimating the term…
Abstract
The present invention relates to AUR1 and/or AUR2 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for AUR1 and/or AUR2 related diseases or conditions characterized by an abnormal interaction between a AUR1 and/or AUR2 polypeptide and a AUR1 and/or AUR2 binding partner.
Claims6
A method for identifying a substance that modulates at least one of AUR-1 or AUR-2 activity comprising the steps of:
- (a) contacting at least one of an AUR-1 polypeptide comprising SEQ ID NO:3 or AUR-2 polypeptide comprising SEQ ID NO:4 with a test substance;
- (b) measuring an activity of said polypeptide;
- and
- (c) determining whether said substance modulates the activity of said polypeptide.
A method of identifying a substance that modulates at least one of AUR-1 or AUR-2 activity in a cell comprising the steps of:
- (a) expressing at least one of an AUR-1 polypeptide comprising SEQ ID NO:3 or AUR-2 polypeptide comprising SEQ ID NO:4 in a cell;
- (b) adding a test substance to said cell;
- and
- (c) monitoring a change in cell phenotype or the interaction between the AUR-1 or AUR-2 polypeptide and a natural binding partner.
Dependencies are inferred from the claim text.